查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1576860

Granisetron市场：按产品类型、应用、最终用户、分销管道划分 - 全球预测 2025-2030

Granisetron Market by Product Type, Application, End Users, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年Granisetron市场价值为70.1亿美元，预计到2024年将达到74.3亿美元，复合年增长率为6.58%，预计到2030年将达到109.6亿美元。

Granisetron是一种选择性5-HT3受体拮抗剂，主要用于预防化疗、放射线治疗和术后环境引起的噁心和呕吐。对Granisetron的需求源于其能够有效解决癌症治疗中常见的和使人衰弱的副作用，从而提高患者的生活品质和治疗依从性。Granisetron的应用范围广泛，包括医院、肿瘤诊所和术后恢復中心，使其成为综合癌症治疗方法的重要组成部分。随着经皮贴片和缓释性注射等新配方的开发，以提高便利性和患者依从性，最终用途的范围正在扩大。

主要市场统计
基准年[2023] 70.1亿美元
预测年份 [2024] 74.3亿美元
预测年份 [2030] 109.6亿美元
复合年增长率（%） 6.58%

Granisetron市场受到癌症发病率上升、化疗和放射线治疗日益普及以及药物输送系统进步等因素的影响。新兴国家癌症患者人数的成长带来了市场机会，这些国家的医疗基础设施和癌症治疗的机会正在扩大。此外，专注于个人化医疗和联合治疗的技术创新有望扩大Granisetron的治疗范围，并为医疗保健行业的公司提供竞争优势。

然而，它们面临着许多挑战，包括高昂的市场开拓成本、导致学名药竞争的专利到期以及减缓市场进入的严格监管流程。由于副作用和相互作用，也存在潜在的局限性，这需要仔细的患者管理和配方改进。

为了推动业务成长，公司应专注于生物相似药开发、创新药物输送方法以及针对特定患者需求和当地医疗保健需求的改进配方等研究领域。此外，投资于病患教育倡议和数位健康平台可以提高市场渗透率和品牌忠诚度。在技​​术进步和对改进止吐治疗的持续需求的推动下，市场动态本质上仍然是动态和竞争的。虽然北美和欧洲市场以先进的医疗设施为主，但由于医疗成本和癌症发病率的上升，亚太地区提供了巨大的成长潜力。

市场动态：揭示快速发展的Granisetron市场的关键市场洞察

供需的动态交互作用正在改变Granisetron市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 新兴市场医疗保健基础设施的开拓加速了市场扩张。
    • 不断增长的医疗保健支出推动了Granisetron等先进止吐疗法的采用
    • 製药公司之间的策略联盟加速Granisetron创新和市场渗透
    • 有利的止吐药报销政策推动Granisetron的使用
  • 市场限制因素
    • 避免专利到期及其对Granisetron市场动态的影响
  • 市场机会
    • 使用Granisetron创新癌症治疗并改善癌症患者的护理
    • 扩大Granisetron在胃肠道疾病和噁心治疗中的仿单标示外使用
    • 将Granisetron入个人化医疗改善患者预后
  • 市场挑战
    • 影响Granisetron稳定供应的供应链漏洞

波特五力：驾驭Granisetron市场的策略工具

波特的五力架构是了解Granisetron市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解Granisetron市场的外部影响

外部宏观环境因素在塑造Granisetron市场的业绩动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解Granisetron市场的竞争状况

对Granisetron市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵Granisetron市场供应商绩效评估

FPNV定位矩阵是评估Granisetron市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了Granisetron市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，Granisetron市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 发展中地区医疗基础设施的扩张加速了Granisetron市场的扩张
      • 不断上涨的医疗费用正在推动Granisetron等先进止吐疗法的推出。
      • 製药公司之间的策略联盟推动Granisetron的创新和市场渗透
      • 止吐药优惠报销政策鼓励Granisetron广泛使用
    • 抑制因素
      • 克服专利到期及其对Granisetron市场趋势的影响
    • 机会
      • 利用Granisetron创新肿瘤治疗并改善癌症患者照护
      • 扩大Granisetron在胃肠道疾病和噁心治疗中的仿单标示外使用
      • 将Granisetron入个人化医疗方法，以改善患者的治疗效果
    • 任务
      • 供应链漏洞影响Granisetron的持续可用性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章Granisetron市场：依产品类型

  • 注射液
  • 口服液

第七章Granisetron市场：依应用分类

  • 化疗引起的噁心和呕吐
  • 术后噁心、呕吐
  • 放射治疗引起的噁心和呕吐

第八章Granisetron市场：依最终用户分类

  • 诊所
    • 普通科诊所
    • 肿瘤门诊
  • 居家护理
  • 医院
    • 私立医院
    • 公立医院

第九章Granisetron市场：按通路

  • 医院药房
  • 网路药房
  • 零售药房

第十章Granisetron美洲市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章 亚太地区Granisetron市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲Granisetron市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-535C62918923

The Granisetron Market was valued at USD 7.01 billion in 2023, expected to reach USD 7.43 billion in 2024, and is projected to grow at a CAGR of 6.58%, to USD 10.96 billion by 2030.

Granisetron is a selective 5-HT3 receptor antagonist primarily used to prevent nausea and vomiting caused by chemotherapy, radiation therapy, and post-operative environments. The necessity for Granisetron stems from its effectiveness in addressing a prevalent and debilitating side effect of cancer treatment, thereby improving patient quality of life and treatment compliance. Its applications span hospitals, oncology clinics, and post-surgical recovery centers, forming a crucial component of comprehensive cancer care regimens. The end-use scope broadens as newer formulations such as transdermal patches and extended-release injections are developed, offering both convenience and improved patient adherence.

KEY MARKET STATISTICS
Base Year [2023] USD 7.01 billion
Estimated Year [2024] USD 7.43 billion
Forecast Year [2030] USD 10.96 billion
CAGR (%) 6.58%

The market for Granisetron is influenced by factors such as the rising prevalence of cancer, increasing adoption of chemotherapy and radiotherapy, and ongoing advancements in drug delivery systems. Market opportunities arise from the growth in cancer patient populations in emerging economies, where healthcare infrastructure and access to cancer care are expanding. Additionally, innovations focusing on personalized medicine and combination therapies are poised to expand the therapeutic scope of Granisetron, offering a competitive edge for businesses in the healthcare sector.

However, the market faces challenges, including the high cost of drug development, patent expirations leading to generic competition, and stringent regulatory processes that can delay market entry. Potential limitations also arise from adverse drug reactions and interactions, necessitating careful patient management and drug formulation enhancements.

To drive business growth, organizations should focus on research areas such as the development of biosimilars, innovative drug delivery methods, and enhanced formulations tailored to specific patient needs and regional healthcare demands. Additionally, investing in patient education initiatives and digital health platforms can enhance market penetration and brand loyalty. The nature of the Granisetron market remains dynamic and competitive, driven by technological advancements and a constant demand for improved antiemetic therapies. North American and European markets hold the lion's share due to advanced healthcare facilities, while Asia-Pacific offers substantial growth potential given its increasing healthcare expenditure and cancer incidence rates.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Granisetron Market

The Granisetron Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Expansion of healthcare infrastructure in developing regions accelerates granisetron market expansion
    • Increase in healthcare expenditure supports the adoption of advanced antiemetic treatments such as granisetron
    • Strategic collaborations between pharmaceutical companies drive innovation and market penetration of granisetron
    • Favorable reimbursement policies for antiemetic medications encourage widespread use of granisetron
  • Market Restraints
    • Navigating patent expirations and their impact on Granisetron market dynamics
  • Market Opportunities
    • Leveraging granisetron for innovative oncology therapeutics and cancer patient care improvements
    • Expanding off-label uses of granisetron in treating gastrointestinal disorders and nausea
    • Integrating granisetron into personalized medicine approaches for better patient outcomes
  • Market Challenges
    • Supply chain vulnerabilities impacting the consistent availability of Granisetron

Porter's Five Forces: A Strategic Tool for Navigating the Granisetron Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Granisetron Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Granisetron Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Granisetron Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Granisetron Market

A detailed market share analysis in the Granisetron Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Granisetron Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Granisetron Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Granisetron Market

A strategic analysis of the Granisetron Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Granisetron Market, highlighting leading vendors and their innovative profiles. These include Akorn, Allergan, Amgen, Apotex, Aurobindo Pharma, Baxter International, Cipla, Dr. Reddy's Laboratories, Endo International, Fresenius Kabi, Glenmark Pharmaceuticals, Hoffmann-La Roche, Lupin Pharmaceuticals, Mylan, Natco Pharma, Pfizer, Sandoz, Sun Pharmaceutical, Teva Pharmaceuticals, and Wockhardt.

Market Segmentation & Coverage

This research report categorizes the Granisetron Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Injectable Solution and Oral Solution.
  • Based on Application, market is studied across Chemotherapy-Induced Nausea And Vomiting, Postoperative Nausea And Vomiting, and Radiotherapy-Induced Nausea And Vomiting.
  • Based on End Users, market is studied across Clinics, Homecare, and Hospitals. The Clinics is further studied across General Clinics and Oncology Clinics. The Hospitals is further studied across Private Hospitals and Public Hospitals.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Expansion of healthcare infrastructure in developing regions accelerates granisetron market expansion
      • 5.1.1.2. Increase in healthcare expenditure supports the adoption of advanced antiemetic treatments such as granisetron
      • 5.1.1.3. Strategic collaborations between pharmaceutical companies drive innovation and market penetration of granisetron
      • 5.1.1.4. Favorable reimbursement policies for antiemetic medications encourage widespread use of granisetron
    • 5.1.2. Restraints
      • 5.1.2.1. Navigating patent expirations and their impact on Granisetron market dynamics
    • 5.1.3. Opportunities
      • 5.1.3.1. Leveraging granisetron for innovative oncology therapeutics and cancer patient care improvements
      • 5.1.3.2. Expanding off-label uses of granisetron in treating gastrointestinal disorders and nausea
      • 5.1.3.3. Integrating granisetron into personalized medicine approaches for better patient outcomes
    • 5.1.4. Challenges
      • 5.1.4.1. Supply chain vulnerabilities impacting the consistent availability of Granisetron
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Granisetron Market, by Product Type

  • 6.1. Introduction
  • 6.2. Injectable Solution
  • 6.3. Oral Solution

7. Granisetron Market, by Application

  • 7.1. Introduction
  • 7.2. Chemotherapy-Induced Nausea And Vomiting
  • 7.3. Postoperative Nausea And Vomiting
  • 7.4. Radiotherapy-Induced Nausea And Vomiting

8. Granisetron Market, by End Users

  • 8.1. Introduction
  • 8.2. Clinics
    • 8.2.1. General Clinics
    • 8.2.2. Oncology Clinics
  • 8.3. Homecare
  • 8.4. Hospitals
    • 8.4.1. Private Hospitals
    • 8.4.2. Public Hospitals

9. Granisetron Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospital Pharmacies
  • 9.3. Online Pharmacies
  • 9.4. Retail Pharmacies

10. Americas Granisetron Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Granisetron Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Granisetron Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Akorn
  • 2. Allergan
  • 3. Amgen
  • 4. Apotex
  • 5. Aurobindo Pharma
  • 6. Baxter International
  • 7. Cipla
  • 8. Dr. Reddy's Laboratories
  • 9. Endo International
  • 10. Fresenius Kabi
  • 11. Glenmark Pharmaceuticals
  • 12. Hoffmann-La Roche
  • 13. Lupin Pharmaceuticals
  • 14. Mylan
  • 15. Natco Pharma
  • 16. Pfizer
  • 17. Sandoz
  • 18. Sun Pharmaceutical
  • 19. Teva Pharmaceuticals
  • 20. Wockhardt

LIST OF FIGURES

  • FIGURE 1. GRANISETRON MARKET RESEARCH PROCESS
  • FIGURE 2. GRANISETRON MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GRANISETRON MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GRANISETRON MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GRANISETRON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GRANISETRON MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GRANISETRON MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GRANISETRON MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GRANISETRON MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS GRANISETRON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS GRANISETRON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES GRANISETRON MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES GRANISETRON MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. GRANISETRON MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. GRANISETRON MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GRANISETRON MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GRANISETRON MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GRANISETRON MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GRANISETRON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GRANISETRON MARKET DYNAMICS
  • TABLE 7. GLOBAL GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GRANISETRON MARKET SIZE, BY INJECTABLE SOLUTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GRANISETRON MARKET SIZE, BY ORAL SOLUTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GRANISETRON MARKET SIZE, BY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GRANISETRON MARKET SIZE, BY POSTOPERATIVE NAUSEA AND VOMITING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GRANISETRON MARKET SIZE, BY RADIOTHERAPY-INDUCED NAUSEA AND VOMITING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GRANISETRON MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GRANISETRON MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GRANISETRON MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GRANISETRON MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GRANISETRON MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GRANISETRON MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GRANISETRON MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GRANISETRON MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL GRANISETRON MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL GRANISETRON MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS GRANISETRON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES GRANISETRON MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. SINGAPORE GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH KOREA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. TAIWAN GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. THAILAND GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. VIETNAM GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 152. DENMARK GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 158. EGYPT GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 164. FINLAND GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 170. FRANCE GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. GERMANY GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 182. ISRAEL GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. ITALY GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 194. NETHERLANDS GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 200. NIGERIA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 206. NORWAY GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 212. POLAND GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 218. QATAR GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 224. RUSSIA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 230. SAUDI ARABIA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH AFRICA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 242. SPAIN GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 248. SWEDEN GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 254. SWITZERLAND GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 260. TURKEY GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 266. UNITED ARAB EMIRATES GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED KINGDOM GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 278. GRANISETRON MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 279. GRANISETRON MARKET, FPNV POSITIONING MATRIX, 2023